231 related articles for article (PubMed ID: 22448282)
1. Cannabinoid receptor 2-mediated attenuation of CXCR4-tropic HIV infection in primary CD4+ T cells.
Costantino CM; Gupta A; Yewdall AW; Dale BM; Devi LA; Chen BK
PLoS One; 2012; 7(3):e33961. PubMed ID: 22448282
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of HIV-1 replication in macrophages by cannabinoid receptor 2 agonists.
Ramirez SH; Reichenbach NL; Fan S; Rom S; Merkel SF; Wang X; Ho WZ; Persidsky Y
J Leukoc Biol; 2013 May; 93(5):801-10. PubMed ID: 23463725
[TBL] [Abstract][Full Text] [Related]
3. Global phosphoproteomics of CCR5-tropic HIV-1 signaling reveals reprogramming of cellular protein production pathways and identifies p70-S6K1 and MK2 as HIV-responsive kinases required for optimal infection of CD4+ T cells.
Wiredja DD; Tabler CO; Schlatzer DM; Li M; Chance MR; Tilton JC
Retrovirology; 2018 Jul; 15(1):44. PubMed ID: 29970186
[TBL] [Abstract][Full Text] [Related]
4. Lineage-specific expression of human immunodeficiency virus (HIV) receptor/coreceptors in differentiating hematopoietic precursors: correlation with susceptibility to T- and M-tropic HIV and chemokine-mediated HIV resistance.
Chelucci C; Casella I; Federico M; Testa U; Macioce G; Pelosi E; Guerriero R; Mariani G; Giampaolo A; Hassan HJ; Peschle C
Blood; 1999 Sep; 94(5):1590-600. PubMed ID: 10477684
[TBL] [Abstract][Full Text] [Related]
5. Primary human mammary epithelial cells endocytose HIV-1 and facilitate viral infection of CD4+ T lymphocytes.
Dorosko SM; Connor RI
J Virol; 2010 Oct; 84(20):10533-42. PubMed ID: 20702626
[TBL] [Abstract][Full Text] [Related]
6. Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo.
Glushakova S; Yi Y; Grivel JC; Singh A; Schols D; De Clercq E; Collman RG; Margolis L
J Clin Invest; 1999 Sep; 104(5):R7-R11. PubMed ID: 10487781
[TBL] [Abstract][Full Text] [Related]
7. Understanding Factors That Modulate the Establishment of HIV Latency in Resting CD4+ T-Cells In Vitro.
Anderson JL; Mota TM; Evans VA; Kumar N; Rezaei SD; Cheong K; Solomon A; Wightman F; Cameron PU; Lewin SR
PLoS One; 2016; 11(7):e0158778. PubMed ID: 27383184
[TBL] [Abstract][Full Text] [Related]
8. Moesin is required for HIV-1-induced CD4-CXCR4 interaction, F-actin redistribution, membrane fusion and viral infection in lymphocytes.
Barrero-Villar M; Cabrero JR; Gordón-Alonso M; Barroso-González J; Alvarez-Losada S; Muñoz-Fernández MA; Sánchez-Madrid F; Valenzuela-Fernández A
J Cell Sci; 2009 Jan; 122(Pt 1):103-13. PubMed ID: 19066282
[TBL] [Abstract][Full Text] [Related]
9. Chemokine receptor-usage of clinical HIV-1 isolates obtained from patients with HIV-1 infection in late clinical stages using PHA-blast.
Matsuda S; Miyata M
Microbiol Immunol; 1999; 43(10):967-74. PubMed ID: 10585143
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of HIV coreceptors CXCR4 and CCR5 on CD4(+) T cells during human endotoxemia and after stimulation with (myco)bacterial antigens: the role of cytokines.
Juffermans NP; Paxton WA; Dekkers PE; Verbon A; de Jonge E; Speelman P; van Deventer SJ; van der Poll T
Blood; 2000 Oct; 96(8):2649-54. PubMed ID: 11023494
[TBL] [Abstract][Full Text] [Related]
11. Expression of chemokine receptors CCR5 and CXCR4 on CD4+ T cells and plasma chemokine levels during treatment of active tuberculosis in HIV-1-coinfected patients.
Wolday D; Tegbaru B; Kassu A; Messele T; Coutinho R; van Baarle D; Miedema F
J Acquir Immune Defic Syndr; 2005 Jul; 39(3):265-71. PubMed ID: 15980685
[TBL] [Abstract][Full Text] [Related]
12. Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains.
Huang L; Bosch I; Hofmann W; Sodroski J; Pardee AB
J Virol; 1998 Nov; 72(11):8952-60. PubMed ID: 9765440
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians.
Dubey S; Khalid M; Wesley C; Khan SA; Wanchu A; Jameel S
J Clin Virol; 2008 Sep; 43(1):25-31. PubMed ID: 18462992
[TBL] [Abstract][Full Text] [Related]
14. Crosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in modulating breast cancer growth and invasion.
Nasser MW; Qamri Z; Deol YS; Smith D; Shilo K; Zou X; Ganju RK
PLoS One; 2011; 6(9):e23901. PubMed ID: 21915267
[TBL] [Abstract][Full Text] [Related]
15. T cell-tropic HIV gp120 mediates CD4 and CD8 cell chemotaxis through CXCR4 independent of CD4: implications for HIV pathogenesis.
Iyengar S; Schwartz DH; Hildreth JE
J Immunol; 1999 May; 162(10):6263-7. PubMed ID: 10229873
[TBL] [Abstract][Full Text] [Related]
16. Identification of an unique CXCR4 epitope whose ligation inhibits infection by both CXCR4 and CCR5 tropic human immunodeficiency type-I viruses.
Adachi T; Tanaka R; Kodama A; Saito M; Takahashi Y; Ansari AA; Tanaka Y
Retrovirology; 2011 Oct; 8():84. PubMed ID: 22018245
[TBL] [Abstract][Full Text] [Related]
17. The puzzling role of CXCR4 in human immunodeficiency virus infection.
Vicenzi E; Liò P; Poli G
Theranostics; 2013; 3(1):18-25. PubMed ID: 23382782
[TBL] [Abstract][Full Text] [Related]
18. Promonocytic U937 subclones expressing CD4 and CXCR4 are resistant to infection with and cell-to-cell fusion by T-cell-tropic human immunodeficiency virus type 1.
Moriuchi H; Moriuchi M; Arthos J; Hoxie J; Fauci AS
J Virol; 1997 Dec; 71(12):9664-71. PubMed ID: 9371631
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes.
Ghosh S; Preet A; Groopman JE; Ganju RK
Mol Immunol; 2006 Jul; 43(14):2169-79. PubMed ID: 16503355
[TBL] [Abstract][Full Text] [Related]
20. Enhanced replication of R5 HIV-1 over X4 HIV-1 in CD4(+)CCR5(+)CXCR4(+) T cells.
Roy AM; Schweighardt B; Eckstein LA; Goldsmith MA; McCune JM
J Acquir Immune Defic Syndr; 2005 Nov; 40(3):267-75. PubMed ID: 16249699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
